Released on: November 9, 2007, 7:31 am

Press Release Author: Buzz121

Industry: Healthcare

Press Release Summary: While little progress in the treatment of cancer has been
made in recent years, Development of specific therapies, based on the Cancer stem
cell hypothesis, are giving hope for improvement of survival and quality of life for
cancer patients.

Press Release Body: New theories, upon which NextGen Bioscience base their work,
have shown that treatments targeted at cancer stem cells could prove to be far
superior to traditional treatments used today. NextGen theories apparently state
that tumors arise from cancer stem cells which, like adult stem cells, have the
ability to self renew and differentiate into multiple cell types, thereby causing
the disease to relapse and give rise to new tumours in patients.


NextGen's business model concentrates on recent discoveries supporting that most
tumours are derived from of a single cancer-initiating cell having stem cell
properties, a cancer stem cell.

NextGen are said to believe that problems with traditional treatment lie in the fact
the efficacy of these treatments are, only really in the early stages of testing,
and are simply by the amount of tumour mass they kill off. As cancer stem cells form
a very small proportion of the tumour, NextGen feel that this may not necessarily be
effective, as traditional therapies leave behind stem cells which may cause a
relapse of the disease. NextGen's aim is to develop targeted, specific therapies
which could offer hope to sufferers of the killer disease.

Web Site: http://www.bakerwilcox.co.uk/nextgen/

Contact Details: NextGen Bioscience, Inc
c/o MC Bio,
46 Aldgate High Street
EC3N 1AL London, U.K.
Attn. Graham May, Company Secretary

Phone: +44 (0)20 7377 6969
Fax: +44 (0)20 7377 9454

Email : info@nextgenbioscience.com